Telix Pharmaceuticals’ Illuccix gets US FDA label expansion to add patient selection for radioligand therapy
Melbourne-headquartered Telix Pharmaceuticals Limited, a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies, announced that the United States …